Nrf2 plays a vital role in the onset, progression, and treatment of neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease [54,55,56]. Here, NFE2L2 is linked to early-onset autosomal dominant Alzheimer disease.